Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
To find and validate new targets for cancer therapies these are accomplished by several methods including candidate identification through tumor genetic analyses, proteomic screens and high-throughput forward genetic (e.g. siRNA) screens. This is comprised of investigators with expertise in X-ray crystallography, NMR and computer modeling.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi